Marina GarcÚs and Dimitri Dorcaratto, professors at the Department of Human Anatomy and Embryology of the University of Valencia, are the main researchers of the 3D-PANC Study, which will be developed with help from the Spanish Association of Surgeons and which could become the first prospective clinical validation study of this type of 3D technology in patients undergoing preoperative chemotherapy for pancreatic cancer.
The current treatment of pancreatic cancer is based on surgery and chemotherapy, but it is difficult to interpret the extent of the tumour from the images obtained by conventional techniques to decide whether or not to operate on patients. The study, with a duration of two years, responds to the need to scientifically validate the precision of three-dimensional (3D) imaging technology compared to conventional computed tomography (CT) in the preoperative staging of patients with borderline or locally advanced pancreatic adenocarcinoma (ACP).
The aim is to be able to more accurately determine which patients can have a pancreatic tumour successfully removed and which patients cannot, and thus avoid unnecessary surgery. This is a prospective, multicentre study in which 16 other reference centres in pancreatic surgery nationwide will participate.
GarcÚs and Dorcaratto are also researchers from the INCLIVA General and Digestive Surgery Research Group and associate physicians from the Hepato-Bilio-Pancreatic Surgery Unit of the General Surgery and Digestive System
The University of Valencia participates in the Igualment Fest with its workshop ’Virus hunters’ - 21.11